Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>A new outbreak of the Ebola virus has been reported in the Democratic <keyword id="248611" type="COUNTRY" weightage="20" keywordseo="Republic-of-Congo">Republic of Congo</keyword> as per the World Health Organisation (WHO). </li><li>The African country, while battling the ongoing coronavirus pandemic, is also home to the world’s largest measles outbreak. </li><li>The WHO expects more outbreaks of Ebola to emerge in the Republic of Congo in the coming months. </li></ul>A new outbreak of the Ebola virus has been reported in the Democratic Republic of Congo. The announcement by the World Health Organisation (<a href="https://www.who.int/news-room/detail/01-06-2020-new-ebola-outbreak-detected-in-northwest-democratic-republic-of-the-congo-who-surge-team-supporting-the-response">WHO</a>) comes at the time the African country is already battling the coronavirus pandemic and the world’s largest measles outbreak. <table style="border-width: initial; border-style: none; width: 468pt; table-layout: fixed;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Virus </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Total cases </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Deaths </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">COVID 19 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">3,195 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">72 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Measles </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">369,520 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">6,779 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Ebola (Mbandaka) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">6 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">4 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Ebola (Noth Kivu, South Kivu and Ituri) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">3463 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">2280 </td></tr></tbody></table> The Ebola virus resurgence has been reported in the Wangata health zone of Mbandaka. So for six cases have been detected of which four have already been reported dead and two are under medical care. “It is likely more people will be identified as surveillance activities increase,” the WHO said in its report. This is the 11th outbreak of Ebola reported in the Republic of Congo since the virus was first detected in 1976. For Mbandaka and its surrounding districts, it is the 9th incident between May to July 2018. The country’s Ministry of Health had early announced the initiation of the 42-day countdown to declare the end of the last <keyword id="1373892" type="PERSON" weightage="20" keywordseo="Ebola-Outbreak">Ebola outbreak</keyword> reported in North Kivu, South Kivu and Ituri provinces on 14 May 2020. The coronavirus pandemic isn’t the only battle the world faces “This is a reminder that COVID-19 is not he only health threat that people face,” said WHO Director-General, Tedros Adhanom Ghebreyesus. The world’s leading health agency expects more outbreaks of Ebola to emerge in the Republic of Congo in the coming months. It believes the existence of the virus in animal reservoirs of the country puts at risk. Even in India, with the upcoming monsoon, doctors believe that the country will have to battle annual disease like malaria, dengue and chikungunya along with the ongoing coronavirus pandemic. “India has proven its dedication to ending malaria, reflected through the diverse involvement in malaria programs of political, government leadership, community leaders and civil society,” said <a href="https://www.businessinsider.in/science/health/news/india-could-see-a-resurgence-of-malaria-as-health-systems-are-busy-containing-covid-19/articleshow/75370206.cms">Sanjeev Gaikwad</a>, India’s country director of Malaria No More. According to the WHO, India has the 5th fifth highest incidence of malaria cases in the world. It reported as many as 430,000 cases of the disease in 2018. However, this time around the country is busy battling the outbreak of coronavirus as numbers continue to rise and experts are uncertain is the requisite precautionary measures against malaria will get any attention. “If these effective programs could start immediately, and safely, after the lockdown is lifted and before the onset of the monsoon rains in early June, India’s progress against malaria can be maintained,” he Gaikwad. SEE ALSO:

Ebola makes a comeback in the Republic of Congo — which is already fighting the coronavirus and the world's largest outbreak of measles

<ul class="summary-list"><li>A new <keyword id="6379474" type="ORGANIZATION" weightage="60" keywordseo="cdc">CDC</keyword> analysis found that after the state of Michigan went into shutdown on March 23, vaccination rates fell.</li><li>The CDC issued a warning to the public about a possible <keyword id="431820" type="PERSON" weightage="60" keywordseo="measles-outbreak">measles outbreak</keyword> if children were not vaccinated properly. </li><li>The data from Michigan shows an emerging trend in declining childhood vaccinations, both in America and abroad.</li><li><a href="https://www.businessinsider.com/?hprecirc-bullet">Visit Business Insider's homepage for more stories</a>.</li></ul>Child vaccination rates have dropped dramatically in one US state, stoking concerns among public health officials that the lockdown could pose serious public health risks unrelated to the <keyword id="1754604" type="PERSON" weightage="60" keywordseo="coronavirus">coronavirus</keyword> pandemic. According to a new <a href="https://www.cdc.gov/mmwr/volumes/69/wr/mm6920e1.htm?s_cid=mm6920e1_x">CDC analysis</a> on vaccinations in Michigan, around 66% of five-month-olds were vaccinated each year from 2016 to 2019. That dropped sharply to 49% in 2020.Overall, the vaccination rate for Michigan children under 18 years old decreased by 21.5%. It comes after the CDC issued a <a href="https://www.businessinsider.com/the-cdc-is-warning-the-public-about-potential-measles-outbreaks-2020-5">warning</a> to the public about a possible resurgence of measles. The new report builds on data showing an emerging trend in the decline of childhood vaccinations, both in America and <a href="https://www.who.int/immunization/diseases/measles/statement_missing_measles_vaccines_covid-19/en/">internationally.</a>While many doctors have transitioned to telemedicine during <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword>, vaccinations still require an in-person doctor's visit, something many parents are leery of during a pandemic.<div type="image" title="measles vaccine" height="1648" width="2197" msid="75815597" hostid="261"></div>Michigan officially went into shutdown on March 23, and vaccination rates immediately fell. The only vaccine rate that did not fall was the Hepatitis B vaccine, which is typically administered after birth in the hospital.For children on a government health insurance program like Medicaid, vaccination rates were even lower than for children on private insurance. Only 34% of Medicaid-enrolled children were up to date with their vaccinations, compared to 55% of children not enrolled in Medicaid.The study authors advised doctors on strategies they could use to make in-person vaccination visits safer, from dedicating specific, separate rooms to sick visits and routine check-up visits, limiting the amount of patients in the office at one time, and having parents call to check-in and receive their vaccinations in the parking lot."The observed declines in vaccination coverage might leave young children and communities vulnerable to vaccine-preventable diseases such as measles," the study authors wrote. "If measles vaccination coverage of 90-95% is not achieved, measles outbreaks could occur."<h2>Without widespread vaccination, everyone can be at risk</h2>Proper measles vaccination is split into two different shots. The first measles vaccination shot is given at 12 to 15 months, and the second is given between the ages of four and six. Without both shots, the child has not been fully vaccinated against measles. During this pandemic, many children may be missing their final measles shot.Without a vaccine to combat it, measles is one of the most contagious diseases there is, and according to the <a href="https://www.who.int/immunization/diseases/measles/statement_missing_measles_vaccines_covid-19/en/">World Health Organization,</a> over 117 million children all over the world are currently at risk of missing their vaccines.Measles is an airborne disease, which means just entering the room of someone <keyword id="6366244" type="UNKNOWN" weightage="60" keywordseo="who">who</keyword> is sick can spread an infection, and 90% of people who come in contract with measles will get infected, according to the <a href="https://www.cdc.gov/dotw/measles/index.html">CDC.</a>"Measles is way more infectious than COVID is, so it's something to be much more feared than being exposed to COVID," Dr. Lee Atkinson-McEvoy, chief of general pediatrics at UCSF, told <a href="https://abc7news.com/measles-outbreak-vaccine-can-you-die-from-is-live/6177709/">ABC7.</a>One <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802703/">2015 estimate</a> shows that if vaccinations were stopped, 2.7 million people would die from measles. In 2018, thanks to a combination of anti-vaxxers and misinformation, as well as lack of access, <a href="https://www.who.int/news-room/detail/05-12-2019-more-than-140-000-die-from-measles-as-cases-surge-worldwide">over 140,000 people</a> died from measles, most of whom were babies and young children. With proper vaccinations, most of those deaths could have been prevented.Richard Mihigo, program manager for immunization at the World Health Organization's Africa office, says historically, measles outbreaks have occurred during epidemics, when people have neglected to vaccinate."We saw this during the [2013-2016] Ebola outbreak in West Africa, where we had an outbreak of measles at the same time," he told <a href="https://medicalxpress.com/news/2020-04-polio-measles-outbreaks-inevitable-vaccine.html">Medical XPress.</a> "And recently we've seen in the Democratic Republic of Congo that an ongoing outbreak of measles has killed more people than the ongoing outbreak of Ebola. But all attention was on Ebola.""Concerted efforts are needed to ensure rapid catch-up for children who are not up-to-date with measles-containing vaccines," the study authors wrote.Read the original article on <a href="https://www.businessinsider.com/child-vaccinations-drop-in-michigan-after-cdc-warning-about-measles-2020-5">Business Insider</a>

Michigan reports a sharp drop in child vaccinations after the CDC warned missed shots could lead to a measles resurgence across the US

<div class="KonaFilter image-container display-table"><div><div class="image"></div></div></div><ul class="summary-list"><li>An Ebola outbreak in DRC has now killed over 1,000 people.</li><li>The executive director of the WHO's Health Emergencies Programme said in a press conference on Friday that the organization expects, "a scenario of continued intense transmission."</li><li>Containment of the virus has been hampered by armed attacks on treatment centers.</li><li><a href="https://www.businessinsider.com/?hprecirc-bullet">Visit Business Insider's homepage for more stories.</a></li></ul>An outbreak of Ebola in the Democratic Republic of Congo (DRC) has claimed 1,000 lives as of Friday, and the World Health Organisation (WHO) is worried it will continue to snowball.Speaking at a press conference early on Friday, executive director of the WHO's Health Emergencies Programme Michael Ryan said as of May 1, there had been 1,510 cases of Ebola in DRC's North Kivu and Ituri provinces, including 994 deaths. <a href="https://uk.reuters.com/article/us-health-ebola-who/congo-ebola-deaths-surpass-1000-as-attacks-on-treatment-centers-go-on-idUKKCN1S9161">Reuters reported later that day</a> that the death toll had exceeded 1,000, making it the second-worst Ebola outbreak on record.Although more than 100,000 people have already been vaccinated and the WHO is planning to expand its vaccination efforts, Ryan said the organization fears the situation will worsen. "We are anticipating a scenario of continued intense transmission," he said.Read more: <a href="https://www.businessinsider.com/vaccine-problem-anti-vaccine-movement-united-states-explained-charts-2019-4?r=US&amp;IR=T">Measles is a public health emergency in the US - these 15 charts explain the vaccine problem</a>Treatment centers are not only having to contend with the disease, but also attacks from armed militias."Since January we've experienced 119 separate attacks, 42 of which have been directly on health facilities with 85 health personnel either injured or killed in those settings. So we are dealing with a difficult and volatile situation," said Ryan."Fundamentally, every time we have managed to regain control over the virus and contain its spread we have suffered major, major security events," he added.Last month the <a href="https://www.who.int/news-room/detail/30-04-2019-statement-from-who-high-level-mission-to-butembo-drc-ebola-situation-worsening-while-support-lags">WHO said in a press statement</a> that WHO epidemiologist Dr. Richard Mouzoko had been killed by armed men while working to contain the disease.

An Ebola outbreak has killed more than 1,000 people in the Democratic Republic of Congo, and containment efforts are being hampered by armed attacks

The <keyword id="22667872" type="General" weightage="100" keywordseo="mpox-outbreak" source="keywords">mpox outbreak</keyword> in <keyword id="19924003" type="General" weightage="20" keywordseo="africa" source="keywords">Africa</keyword> is yet another example of how <keyword id="20040661" type="General" weightage="20" keywordseo="infectious-diseases" source="keywords">infectious diseases</keyword>, perceived to be "someone else's problem", and affecting mainly poor, developing countries, may suddenly pose unexpected global threats. Other examples of <keyword id="22817243" type="General" weightage="20" keywordseo="neglected-diseases" source="keywords">neglected diseases</keyword> include the West Nile, Zika and Chikungunya viruses. Mpox was discovered in 1958 (in captive monkeys, hence the original misnomer "monkeypox") and the first human case was identified in 1970. Then, for decades it was largely neglected by the scientific and public health communities, regarded as an uncommon infection in remote rural areas in tropical Africa, without relevance for the rest of the world. When a massive mpox outbreak hit developed countries in 2022, increased research funding led to a surge in scientific studies. On just one medical search engine, there's been more research produced since April 2022 than in the preceding 60 years. The 2022-23 global mpox outbreak happened despite repeated calls from African researchers for increased global investment in diagnostic, therapeutic and infection prevention tools for mpox. The WHO has now declared the current upsurge of mpox in central Africa a <keyword id="21952478" type="General" weightage="20" keywordseo="public-health-emergency" source="keywords">public health emergency</keyword> of international concern. This is the highest alert level for events that constitute a public health risk to other countries and requires a coordinated international response. Mpox's recent history is yet another reminder that an infectious disease in one corner of the world should not be regarded as someone else's problem, as it can suddenly start to spread fast and far. It also highlights global inequities in resource allocation and access to vaccines, diagnostics and treatments. These were made available in many industrialised countries and helped curb the global outbreak, but are still largely lacking in most of Africa. <h2>The 2022 outbreak: a total surprise</h2>The disease has been renamed "mpox" but the name of the virus, for now, remains "monkeypox" (MPXV). It is closely related to the smallpox virus. MPXV was considered a <keyword id="21311828" type="General" weightage="20" keywordseo="zoonotic-disease" source="keywords">zoonotic disease</keyword> endemic in parts of central and west Africa. It was acquired mainly through close contact with wild mammals, especially handling bush meat, but there was no sustained human-to-human transmission. Only very occasionally were cases seen outside the endemic areas, due to infected travellers or import of infected small mammals. This changed abruptly in 2022: a massive, rapidly evolving global outbreak caused over 99,000 laboratory-confirmed cases in 116 countries. At its peak in August 2022, over 6,000 cases were reported each week. This outbreak came as a total surprise: most cases were reported from non-endemic countries, mostly in men who have sex with men, who had become infected during recent sexual encounters. Even though most cases were clinically not particularly severe and the death toll stands at just over 200, the global outbreak was declared a public health emergency of international concern by the <keyword id="19896311" type="General" weightage="20" keywordseo="world-health-organization" source="keywords">World Health Organization</keyword> on 23 July, 2022. Fortunately, case numbers soon plummeted due to a combination of behavioural changes and vaccination in at-risk groups. Modern vaccines and antiviral drugs with activity against mpox were made available in many affected high-income countries. These had been developed and stockpiled in the US and Europe, mostly in preparation for a potential bioweapon attack using a poxvirus. The global outbreak in 2022 was caused by clade II of MPXV, which is endemic in west Africa and not as virulent as clade I MPXV, which so far has only been seen in the Congo Basin. That first mpox public health emergency of international concern was declared over in May 2023. Clade II MPXV infections are still occurring globally, but the worst seems over - for now. Complacency would be misguided, as illustrated by the current mpox outbreak that is gathering steam. <h2>Upsurge in Africa</h2>The African region is experiencing an upsurge in mpox cases, which started in 2023. As the continent which includes the areas where mpox has been endemic for a long time, Africa now presents a complex mosaic. The current clade I MPXV (formerly called Congo Basin strain) is more virulent than the clade II (west African) strain, resulting in a higher case fatality rate. The ongoing outbreak has its epicentre in South Kivu province, eastern DRC, and has the potential to fuel a large pandemic. It has a distinct epidemiological pattern with sustained chains of human-to-human transmission, often via the sexual route. It may have increased transmissibility (we don't know yet). The virus which causes it is the newly defined clade Ib lineage. It displays mutations that are the hallmark of human-to-human spread that is estimated to have been happening since September 2023. Case numbers are rising rapidly, even though many suspected cases are likely not tested and thus not counted as confirmed. Complicating matters, a commonly used test was found to miss infections with this lineage of the virus. It affects mostly adults. The case fatality rate is higher than it was in the 2022 global outbreak. Already, this outbreak has resulted in mpox cases occurring in several neighbouring countries, including some (like Kenya), with no previous record of mpox. The challenge is enormous. The eastern DRC is an area beset by multiple problems. This includes natural disasters, violence and infectious diseases including measles, cholera and poliomyelitis for the DRC. In recent years the second-largest Ebola outbreak ever took place in the wider area and, despite the availability of vaccines and treatments, posed considerable challenges. <h2>What needs to happen</h2>Equitable access to diagnostic tests, vaccines and antiviral treatments requires political commitment and financial investments. Scientific investigations are needed to learn more about exposure settings, transmission routes and clinical presentations. It's important to find the best ways to make these interventions. There is no doubt that a disease in one corner of the world can suddenly become a global heath threat. It's time the global health system woke up to this reality.

Mpox outbreak in Africa was neglected - it could now turn into the next global pandemic

A team of researchers at the <keyword id="150557" type="General" weightage="20" keywordseo="university-of-oxford" source="Orion">University of Oxford</keyword> on Thursday rolled out the first human trials of an <keyword id="2465451" type="General" weightage="20" keywordseo="Ebola-vaccine" source="Orion">Ebola vaccine</keyword> developed using the same technology as the AstraZeneca Covid jab. The trial will be conducted on 26 volunteers, aged between 18 and 55 years, to determine the safety and immunogenicity of the vaccine called ChAdOx1 biEBOV. It will assess the vaccine's efficacy and the immune response it creates against Zaire and Sudan Ebola virus species in healthy adult volunteers. "We are carrying out a clinical trial of a new Ebola vaccine called 'ChAdOx1 biEBOV' which is designed to target two of the deadliest species of Ebola-causing viruses," according to a statement of the Jenner Institute, University of <keyword id="46985" type="General" weightage="100" keywordseo="oxford" source="Orion">Oxford</keyword>. The vaccine is based on the ChAdOx1 vaccine technology that was previously successfully used to develop the <keyword id="9610841" type="General" weightage="20" keywordseo="oxford/astrazeneca" source="Orion">Oxford/AstraZeneca</keyword> Covid-19 vaccine. It is developed using adenovirus -- a weakened version of the common cold virus that is genetically modified so that it cannot replicate in humans. The trial participants will be monitored over a six-month period, with results expected in the second quarter of 2022. Ebola is a severe, often fatal illness that is transmitted to people from wild animals and then spreads in the human population through direct contact with the blood, secretions, organs or other bodily fluids of infected people. There are four species of Ebola virus that have been known to cause disease in humans. Of these, Zaire is the most lethal, causing death in 70-90 per cent of cases if left untreated. While rVSV-ZEBOV vaccine is currently approved against Ebola, the research team believes "the world needs new vaccines against Ebola". "This disease can be caused by several different species of virus and each of these may require a targeted immune response to offer protection," Dr Daniel Jenkin, principal investigator of the trial at the Jenner Institute, University of Oxford, was quoted as saying by The Telegraph. "We have designed our new vaccine to target the two species of virus that have caused nearly all Ebolavirus outbreaks and deaths, and now look forward to testing this in phase one clinical trials," he added. The Democratic Republic of Congo is currently seeing an outbreak with eight cases, including six deaths reported since the beginning of October. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/science/health/news/over-22-million-infants-missed-first-dose-of-measles-vaccine-in-2020-due-to-covid-19-says-who/articleshow/87641962.cms">Over 22 million infants missed first dose of measles vaccine in 2020 due to COVID-19, says WHO</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/careers/news/oil-is-actively-recruiting-146-people-in-different-domains-in-india-with-a-pay-scale-upto-37000-per-month/articleshow/87645094.cms">OIL is actively recruiting 146 people in different domains in India with a pay scale upto ₹37,000 per month</a>

Researchers at the University of Oxford start first human trials of Ebola vaccine

<ul class="summary-list"><li>The world could see a re-emergence of another infectious disease as it tries to grapple with containing the new <keyword id="1754604" type="PERSON" weightage="60" keywordseo="coronavirus">coronavirus</keyword>. </li><li>Some countries are facing shortages or obstacles in obtaining necessary <keyword id="79555" type="TECHNOLOGY" weightage="60" keywordseo="Vaccines">vaccines</keyword> for diseases like polio or measles, the <a href="https://apnews.com/d9f396c628e10ab03ebb55b6302c81e9">Associated Press</a> reported. </li><li>People dealing with chronic infections may not have access to necessary medications they need to stay alive. </li><li><a href="https://www.businessinsider.com/?hprecirc-bullet">Visit Business Insider's homepage for more stories</a>.</li></ul>Efforts to eliminate or control the spread of infectious diseases like tuberculosis, measles, malaria, polio, HIV/AIDS, among others, may be thwarted as the world focuses on the coronavirus pandemic. The issue is global, from African countries struggling to get necessary vaccines to countries like South Korea that have robust healthcare systems, according to the <a href="https://apnews.com/d9f396c628e10ab03ebb55b6302c81e9">Associated Press</a>. <h2>Resources could run out as they are being used to battle the coronavirus</h2>John Nkengasong, head of the Africa Centers for Disease Control and Prevention, told the AP that hospitals are so overwhelmed with coronavirus that they're redirecting medical staff, running short on supplies, and suspending health services. Tolbert Nyenswah, a research associate at Johns Hopkins University, told Business Insider that hospitals on the continent lack personal protective equipment for medical staff. If a worker gets sick, the facility is likely to close, leaving an entire community of people who rely on it for care and medications at risk. Nkengasong added the biggest concern is that resources used for other diseases would be repurposed for coronavirus or run out. <h2>In Liberia, over 10,000 people died from other preventable diseases during the Ebola crisis</h2>Business Insider <a href="https://www.businessinsider.com/people-with-other-illnesses-pay-price-coronavirus-containment-2020-2">previously reported</a> that in China, people with other illnesses were struggling to get care as the country imposed a serious lockdown and sent healthcare workers from across the country to Wuhan to fight the outbreak. "There are other things that are catastrophic for the population," Nyenswah told Business Insider.Nyenswah, who previously served in Liberia's health ministry, where he battled the country's 2014-2016 Ebola crisis, spoke on how over 10,000 people died from three other preventable diseases during that outbreak because they were unable to get care. He predicts the current coronavirus pandemic will have a much more significant death toll from other diseases. "All the cases of death will be triple or quadruple or even ten times the COVID deaths," Nyenswah said. He explained that millions of kids could miss out on vital vaccines that they get in childhood due to delays, leaving them vulnerable to infections from things like yellow fever, measles, and polio, especially in Africa, Asia, and southeast Asia. Others could die from diseases like HIV/AIDS and tuberculosis if their healthcare facilities where they access those necessary medications and treatments close. "This will have longtime consequences for decades to come," Nyenswah said, <h2>Lockdowns can keep people from life-saving medications</h2>Rashid Ansumana, a Sierra Leone health expert who studied the Ebola outbreak, told the AP that the impact of the coronavirus's "will definitely be higher."<a href="https://www.wsj.com/articles/patients-without-coronavirus-struggle-to-get-urgent-care-in-china-11582134713?mod=hp_lead_pos1">The Wall Street Journal</a> also reported that people were already feeling the impact of the pandemic. Wan Ruyi, a college student with acute lymphoblastic leukemia, told WSJ she was unable to access necessary care because of the lockdown at the time, many people were unable to get refills on life-saving medications. Emily Ricotta, a research fellow at the National Institute of Allergy and Infectious Diseases, previously told Business Insider that it's not uncommon to see these sorts of shortages in care for people dealing with other illnesses in times of outbreaks. When the focus is on containing an outbreak, there are fewer resources available to deal with other conditions. "When an outbreak starts, the first response is containment," Ricotta said. Marc Biot, director of operations for Doctors Without Borders, told the AP health providers are working to give people who have hepatitis C, HIV and Tuberculosis months worth of medicine. <h2>"Countries that are on track to eradicate diseases like polio and measles, they may be compromised"</h2>However, on a global level, the AP reports that struggles to get necessary vaccines where they're needed most could mean entire segments of populations could miss out on vital protection from viruses that were on their way to being eradicated. The vaccine alliance <a href="https://measlesrubellainitiative.org/measles-news/more-than-117-million-children-at-risk-of-missing-out-on-measles-vaccines-as-covid-19-surges/">GAVI</a> said 13.5 million people are at risk of contracting measles, polio, and human papillomavirus. The organization also said there were 21 countries mainly in African facing shortages of vaccines because of borders closing and limited airplanes operating. Additionally, 14 "vaccination campaigns for diseases like polio and measles have been postponed.""Countries that are on track to eradicate diseases like polio and measles, they may be compromised," Nyenswah said. Biot told the AP that lockdowns have also made it hard to transport supplies such as necessary medication, protective gear, and oxygen. The Congo is already dealing with new Ebola and measles outbreaks that have caused more than 6,000 deaths, according to the AP.According to <a href="https://www.nytimes.com/2020/04/13/health/coronavirus-measles-vaccines.html">the New York Times</a>, 100 million kids could be at risk for measles due to halted vaccine programs. There are already dealies to measles vaccines in 24 countries and concern that over 117 million children in 37 countries could miss out on the necessary immunization, <a href="https://measlesrubellainitiative.org/measles-news/more-than-117-million-children-at-risk-of-missing-out-on-measles-vaccines-as-covid-19-surges/">The Measles &amp; Rubella Initiative</a>.Door-to-door vaccinations from the Bill &amp; Melinda Gates Foundation recommended were suspended, Jay Wenger, who heads polio eradication efforts told the AP. "It is a necessary move to reduce the risk of increasing transmission of COVID-19," Wenger told the AP. India has seen a delay in diagnosing tuberculosis patients amid lockdowns that prevent people from accessing healthcare clinics. The country has around one-third of the global tuberculosis cases. Health inspectors in Sri Lanka that typically work to destroy mosquito breeding sites in homes have been working on tracking coronavirus cases. The country saw an increase in the mosquito-born disease like dengue fever last year, according to the AP. Despite the need to address and limit the spread of the coronavirus, Nkengasong told the AP there still needs to be an immediate focus on addressing all the other illnesses that could run rampant and cause more deaths. As for right now, Nyenswah recommends an approach that focuses on providing personal protective equipment to healthcare workers across the globe, especially in areas where people rely on facilities remaining open for medications, maintaining routine vaccinations alongside the efforts to stop the spread of the coronavirus. "The time to advocate for those programs is not when COVID is over. The time is now," Nkengasong told the AP.Nyenswah said there needs to be one health approach to dealing with infectious and emergent diseases. The <a href="https://www.cdc.gov/onehealth/index.html">One Health</a> approach is a CDC initiative that focuses on a collaborative approach between health, political and environmental organizations on the local, regional, and international levels "with the goal of achieving optimal health outcomes recognizing the interconnection between people, animals, plants, and their shared environment."Nyenswah explained that humans, animals, and the environment are closely linked, and disease is easier to spread from animals to humans, primarily due to environmental factors like humans pushing further into forested areas and interacting more closely with animals. To address the infectious diseases that can spread as a result, including the current coronavirus pandemic, experts in different fields and at all levels need to understand when and where a virus might emerge. He said the focus should on "how do we look at the outbreaks and stop them at their source?" Read the original article on <a href="https://www.businessinsider.com/other-infectious-disease-spread-amidst-efforts-stop-covid-19-2020-4">Business Insider</a>

While the world is focused on containing the new coronavirus, we could lose our fight against other infectious diseases, some that were on their way to being eradicated

<ul class="summary-list"><li>On Friday, President <keyword id="6354862" type="UNKNOWN" weightage="60" keywordseo="trump">Trump</keyword> said the US was "terminating" its relationship the World Health Organization. </li><li>On Monday, the <keyword id="6366244" type="UNKNOWN" weightage="60" keywordseo="who">WHO</keyword> director-general said he heard the <keyword id="6355005" type="UNKNOWN" weightage="60" keywordseo="news">news</keyword> from the media. </li><li>The director-general said it's his organization's "wish" for its collaboration with the US to continue. </li></ul>On Friday, President Trump <a href="https://www.businessinsider.com/trump-says-hes-terminating-us-relationship-with-world-health-organization-2020-5">said the US was terminating its relationship with the World Health Organization</a> due to what he sees as its China-centric response to the <keyword id="1754604" type="PERSON" weightage="60" keywordseo="coronavirus">coronavirus</keyword>.That was news to the WHO. In response to a reporter's question Monday about when the organization was officially informed of Trump's decision, the WHO director-general Tedros Adhanom Ghebreyesus said, "The announcement was last Friday, as we all heard from the media, and the only communication we had, or announcement, was actually at Friday's media announcement from the US." Earlier in the media briefing out of Geneva, Tedros said he hoped the WHO-US relationship could continue. "The world has long benefited from the strong collaborative engagement with the government and the people of the United States," Tedros said. "The US government and its people's contribution and generosity towards global health over many decades has been immense, and it has made a great difference in public health all around the world. It is WHO's wish for this collaboration to continue." He declined to answer a follow-up question about if or how it's possible for a member state to pull out of the WHO. <h2><div type="image" title="A globe" height="1363" width="2000" msid="76143187" hostid="261"></div></h2>Trump said he's ending the US-WHO relationship because he believes the organization succumbed to pressure by China to "mislead the world" when the coronavirus was discovered in Wuhan. During his announcement Friday, he argued that China "has total control over" the organization.He also said that the US would be "redirecting those funds to other worldwide and deserving urgent global public-health needs."The WHO, however, also directs its funds to pressing health needs outside of the coronavirus; its most immediate other focuses include battling a new Ebola outbreak in the Democratic Republic of the Congo, responding to the world's largest measles outbreak, and seeking solutions for the growing global threat of anti-microbial drug resistance, Tedros said Monday. The US is the organization's <a href="https://www.npr.org/sections/goatsandsoda/2020/04/15/834666123/trump-and-who-how-much-does-the-u-s-give-whats-the-impact-of-a-halt-in-funding">top funder</a>, providing around $450 million a year, according to Trump. The alleged departure has been largely criticized by medical, global health, and public policy professionals and organizations. "We helped create @WHO. We are part of it. It is part of the world. Turning our back on WHO makes us and the world less safe," Dr. Tom Frieden, the former director of the Centers for Disease Control and Prevention, <a href="https://twitter.com/DrTomFrieden/status/1266445681163751424?s=20">tweeted on Friday</a>.It's unclear if or how the president can withdrawal from the WHO; experts <a href="https://www.npr.org/sections/goatsandsoda/2020/05/29/865816855/trump-says-u-s-will-withdraw-from-who-does-he-have-the-authority-to-do-it">told NPR</a> he would only have the authority had Congress decided to give it to him before his announcement. Read the original article on <a href="https://www.businessinsider.com/who-heard-about-trumps-decision-to-terminate-relationship-from-media-2020-6">Business Insider</a>

The WHO heard about Trump's decision to pull out of the organization 'from the media'

<ul class="summary-list"><li>Mass vaccination campaigns are being rolled out around the world as governments look for ways to contain the spread of <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword>.</li><li>Pfizer-BioNTech, Oxford-AstraZeneca, <keyword id="9739267" type="UNKNOWN" weightage="60" keywordseo="Sputnik-V">Sputnik V</keyword>, and Sinopharm are among the authorized vaccines being distributed in multiple countries.</li><li>But Russia, India, and China have been criticized for rushing their <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword> approval processes, and some people remain skeptical about getting inoculated.</li><li>As wealthier nations expand their immunization efforts, many developing countries struggling with the pandemic are still waiting for their shots.</li></ul>Mobile freezers brought onto boats and carried by motorbikes - this is what it takes to deliver measles and Ebola vaccines to remote parts of Congo. The efforts were essential to control those outbreaks, and they can teach us lessons on how to bring the new COVID-19 vaccines to billions of people living in isolated areas of the world. "There's lots of rivers, there's lots of jungles, there's mountains, and there's very few paved roads," said John Johnson, an emergency coordinator with Doctors Without Borders.But delivery of coronavirus shots to these places is still months, <a href="https://www.businessinsider.com/poor-countries-may-wait-years-covid-19-vaccines-2020-11">if not years</a>, away. Despite record levels of infections, many developing countries can't afford to secure vaccines right now and will have to wait on aid.Meanwhile, richer nations are well underway. <h2>Russia's Sputnik V vaccine is making its way around the world. </h2>Russia was the first country to give approval to a human vaccine. Now it's close to giving the green light to one for domestic animals susceptible to contracting the virus from humans.But the country's handling of these efforts has been <a href="https://www.businessinsider.com/russia-approves-coronavirus-vaccine-experts-say-needs-more-testing-2020-8">widely criticized</a>. Its coronavirus vaccine, Sputnik V, received regulatory approval in August, when it had only been tested on a few dozen people.In December, Russia launched a mass vaccination campaign before full trials had finished."I think only time will tell, and that's it," said nurse Natalia Shvekova. "Well, I don't know, but I believe the more people get vaccinated, the better it will be for our health."But that isn't a popular view among Russians. Recent polls have found that more than half of the country doesn't plan on getting the vaccine, at least not until there's more information.Still, doses of Sputnik V are making their way around the world. Just before Christmas, Argentina became the third country to <a href="https://markets.businessinsider.com/news/stocks/argentina-has-registered-the-sputnik-v-vaccine-based-on-russian-clinical-trial-data-1029917789">approve the treatment</a>, after Russia and Belarus.Governments are anxious to gain some sort of control over the pandemic, and it turns out Sputnik V is much <a href="https://www.insider.com/russias-sputnik-v-vaccine-to-be-cheaper-than-rivals-says-fund-head-2020-11">cheaper</a> than the vaccines made by Russia's Western rivals.<h2>Distribution of the Pfizer-BioNTech vaccine has resulted in long lines around the world.</h2><div type="image" title="Vax pic 210" height="1080" width="1920" msid="80160376" hostid="261"></div>The UK was the <a href="https://www.businessinsider.com/pfizer-and-biontech-covid-19-vaccines-approved-by-uk-regulator-2020-11">first to approve</a> Pfizer-BioNTech's vaccine for emergency use. Canada, the US, and the European Union quickly followed suit."It is a significant step forward in our fight against this pandemic, which is causing suffering and hardship for so many people, not just in Europe," said Emer Cooke, executive director of the European Medicines Agency.All over the world, distribution of the <keyword id="44612" type="CITY" weightage="60" keywordseo="Pfizer">Pfizer</keyword> vaccine is resulting in long lines like the ones often seen for COVID tests, as well as makeshift clinics like the ones used for COVID patients.Many felt relief."It's a day of much excitement, seeing this helicopter transporting hope," the president of Chile, Sebastián Piñera, said.Maria Irene Ramirez, a nurse in Mexico, added, "It's the best gift in 2020 I could have gotten."But some are still skeptical. "I am not willing to inject myself with something that I don't know where it was made, what's in it, who touched, who didn't touch it," Jerusalem resident Avishai Atias shared.<h2>The US is off to a slow start vaccinating Americans while other countries are working on their own vaccines.</h2>In the US, mistrust of vaccines has <a href="https://news.gallup.com/poll/327425/willingness-covid-vaccine-ticks.aspx">gradually declined</a>.The Food and Drug Administration gave emergency use authorization to both Pfizer's treatment and a second one developed by <keyword id="4912868" type="PERSON" weightage="60" keywordseo="moderna">Moderna</keyword>, <a href="https://www.businessinsider.com/fauci-got-his-first-coronavirus-vaccine-dose-live-on-tv-2020-12">widening the reach</a> of the country's immunization effort.But the nation with the most infections in the world is off to a slower than expected start. 20 million Americans were supposed to get a shot by the end of 2020. Only <a href="https://www.businessinsider.com/challenges-with-us-coronavirus-vaccine-distribution-warp-speed-goal-2020-12">about 3 million</a> did.Back in the UK, a second vaccine by Oxford-AstraZeneca was also approved just before the new year.Unlike Pfizer's, it doesn't need to be stored in frigid temperatures - making it much <a href="https://www.businessinsider.com/oxford-covid-19-vaccine-pfizer-moderna-compared-astrazeneca-cheaper-temperature-2020-11">easier to transport and store</a>.India has since given the Oxford shot a green light as well, manufacturing a local version called Covishield."It is free across the country," said Indian health minister Harsh Vardhan.India also approved its own government-backed vaccine called Covaxin. But many health experts worry about Covaxin's missing efficacy data, calling the authorization <a href="https://www.bbc.com/news/world-asia-india-55526123">rushed</a>. China has heard similar critiques about its vaccination programs. <a href="https://www.businessinsider.com/china-giving-coronavirus-vaccine-candidate-key-workers-2020-8">Since the summer</a>, it's been administering unproven, homegrown vaccines to parts of its population.Among these is the CoronaVac, made by the company Sinovac.It's already been used on some high-risk groups in China, while being tested in Brazil, Chile, Turkey, and Indonesia. The Chinese state-owned company Sinopharm also has vaccines in development. Despite a <a href="https://www.businessinsider.com/china-approves-sinopharm-vaccine-2020-12">lack of transparency</a> around trial data, the United Arab Emirates and Bahrain have been the first two countries to approve of a Sinopharm vaccine."It was my duty as a Bahraini female and as a doctor as well to take this vaccine, and to be one of the pioneers to take it," said resident Mai Bobshet.<h2>It's impossible to ignore the role of <keyword id="6358883" type="UNKNOWN" weightage="60" keywordseo="politics">politics</keyword> in the vaccine rollout.</h2>Much of the story about whose shots are approved where is turning out to be a political one.In Hungary, the dilemma is noticeable. Even though the country is part of the European Union, and Pfizer's vaccine is already being rolled out, the government is still considering more doses from China and Russia."Countries are playing, and our leaders or politicians are playing, a game," said Balazs Rekassy, health policy advisor to the mayor of Budapest. "Which vaccine can they get first? Hungary is in a special situation, because it is in the middle from East and West."But for the coronavirus, there is no distinction between East and West.And <a href="https://www.businessinsider.com/coronavirus-vaccine-rich-nations-leave-rest-scrambling-supplies-2020-12">those with resources</a> will need to make sure the rest of the world can get its shots, too.

COVID-19 vaccines are making their way around the world, but global immunity is still far off

Vaccines are considered one of <a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm" target="_blank">the greatest public health achievements</a> of the 20th century. They've saved millions of lives. But there are still outbreaks of vaccine-preventable diseases all over the world - including in the United States.
The <a href="http://www.cfr.org/">Council on Foreign Relations</a>, a nonpartisan think tank, has been tracking news mentions of such outbreaks since the fall of 2008, and they've assembled an amazing, <a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">interactive map</a> of them.
In the maps below, each type of illness is identified by a color (Measles / Mumps / Rubella / Polio / Whooping Cough / Other), and larger circles mean more infections (though keep in mind the dots and the maps we've screenshotted here are not all to the same scale).
We've pulled out some interesting things we found as we explored.
Here's a zoomed-out view of all of the vaccine-preventable outbreaks CFR has recorded in North America, with South America, Africa, and parts of Europe and Asia. 
<div class="KonaFilter image-container full"><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">Council on Foreign Relations</a></div></div>Now here's a zoomed-in view of just the U.S.:
<div class="KonaFilter image-container full"><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">Council on Foreign Relations</a></div></div>Outbreaks naturally cluster where there are more people. Cities with large numbers of people who travel internationally may be especially susceptible, as some - not all - outbreaks originate internationally, especially since some of these infections are more prevalent overseas.
Overall, the United States has seen a huge <a href="http://www.businessinsider.com/adult-infection-symtoms-of-whooping-cough-2013-11">resurgence in whooping cough</a> in the last few years. Look at the scene from 2009:
<div class="KonaFilter image-container full"><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">Council on Foreign Relations</a></div></div>Compare the image above to 2012, when all of these whooping cough hotspots popped up. One outbreak in Wisconsin infected almost 6,000 people:
<div class="KonaFilter image-container full"><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">Council on Foreign Relations</a></div></div>Not vaccinating children is a disturbing trend and <a href="http://www.nytimes.com/2008/03/21/us/21vaccine.html?_r=0" target="_blank">a major health risk</a> - unvaccinated children are at least 8 times more likely to get whooping cough than those who have received the recommended pertussis vaccinations. But the CDC says that's not the main reason for the recent spike in whooping cough cases.
The increase is because of "increased awareness, improved diagnostic tests, better reporting, more circulation of the bacteria, and waning immunity," the CDC says. (The whooping cough vaccine gets less effective as we age, which is why <a href="http://www.cdc.gov/media/matte/2011/10_whooping_cough.pdf" target="_blank">boosters</a> are so important.)
On top of the resurgence of whooping cough, 2011 saw measles outbreaks across the country, especially along the Eastern seaboard. These cases were likely due to dropping vaccination rates - 86 percent of those infected were unvaccinated, the <a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6115a1.htm" target="_blank">CDC reported</a>:
<div class="KonaFilter image-container full"><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">Council on Foreign Relations</a></div></div>Other than whooping cough and measles, the vaccine-preventable outbreaks in the United States since 2008 involved meningitis, chicken pox, typhoid, tetanus, and mumps. All of these happened in a country where vaccines are widely available and widely used.
But the U.S. is not not alone among developed nations facing an upwelling of vaccine preventable infections. Here's what the maps look like for Australia and Japan:
<div class="KonaFilter image-container display-table full"><div><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">CFR</a></div></div></div>
<div class="KonaFilter image-container display-table full"><div><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">CFR</a></div></div></div>
The United Kingdom has dealt with a surprising number of measles outbreaks, with the largest affecting more than 2,000 people. France has had fewer measles outbreaks overall, but one 2011 outbreak infected almost 15,000 people. And those numbers are dwarfed by rubella outbreaks in Poland and Romania, which infected more than 39,000 and 24,000 people respectively. Here's the relevant slice of Europe:
<div class="KonaFilter image-container display-table full"><div><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">CFR</a></div></div></div>
The largest measles outbreak we found on the map was in the Democratic Republic of Congo, where measles spread to 134,000 people in 2011. A measles outbreak in India infected almost 30,000 people, and one in China infected more than 52,000.
<div class="KonaFilter image-container display-table full"><div><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">CFR</a></div></div></div>Sierra Leone had a shockingly large outbreak of cholera, a disease that's been completely eradicated in many other countries, and <a href="http://www.doctorswithoutborders.org/news/article.cfm?id=6984" target="_blank">Nigeria</a> (you can see its capital city, Lagos, on this map) seemed to have an especially high concentration of outbreaks overall:
<div class="KonaFilter image-container display-table full"><div><div class="image"><a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map">CFR</a></div></div></div>
While this could be partially because Nigeria is one of the most populous countries in the world, the country's measles outbreaks are especially troubling since they are associated with very high mortality there.
"Children in [Nigeria, Chad, and Niger]," a <a href="http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0040016" target="_blank">2007 study in the journal PLoS Medicine</a> concludes, "still face unacceptably high mortality from a completely preventable disease."
CFR's full map of vaccine-preventable disease is below. Just click on "map" to play around with it for yourself, or visit the larger version <a href="http://www.cfr.org/interactives/GH_Vaccine_Map/#map" target="_blank">on their site</a>.

You Searched For "measles congo" and got 10 results

Ebola makes a comeback in the Republic of Congo — which is already fighting the coronavirus and the world's largest outbreak of measles

Prabhjote Gill

Michigan reports a sharp drop in child vaccinations after the CDC warned missed shots could lead to a measles resurgence across the US

Shira Feder

An Ebola outbreak has killed more than 1,000 people in the Democratic Republic of Congo, and containment efforts are being hampered by armed attacks

Isobel Asher Hamilton,Isobel …

Mpox outbreak in Africa was neglected - it could now turn into the next global pandemic

PTI

Researchers at the University of Oxford start first human trials of Ebola vaccine

IANS

While the world is focused on containing the new coronavirus, we could lose our fight against other infectious diseases, some that were on their way to being eradicated

Sarah Al-Arshani

The WHO heard about Trump's decision to pull out of the organization 'from the media'

Anna Medaris Miller

COVID-19 vaccines are making their way around the world, but global immunity is still far off

Hannah Jiang,Dylan Bank

This Incredible Map Shows All The Infections That Could Have Been Prevented By Vaccines

Lauren F Friedman

Why a coronavirus vaccine won't be ready for public distribution until 2021, according to a top virologist

Guido Vanham and Peter Vanham

Popular Keywords

Buying Guides